バージニアにおけるがん（全種類）の臨床試験
バージニア内の拠点で、がん（全種類）に関する71件の研究が参加者を募集しています。
バージニア内の都市
公式研究テキスト（英語）
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- NEXT Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07529808A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Next Virginia /ID# 279684, Fairfax
被験者募集中第2相
18歳以上 · 女性 · 2026/10/01更新 · NCT07024784A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- Virginia Cancer Specialists ( Site 1102), Fairfax
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07209111A Study of ASP3082 in Adults With Advanced Solid Tumors
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05382559Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Virginia Oncology Associates, Norfolk
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07566156REC-7735 in Participants With Solid Tumors
- NEXT Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07819136Registry Study for Radiation Therapy Outcomes
- Inova Schar Cancer Institute, Fairfax
- Hampton University Proton Therapy Institute, Hampton
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/29更新 · NCT01255748A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Inova Schar Cancer Institute, Fairfax
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07195591A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
- NEXT Oncology, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07612176A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Inova Schar Cancer Institute Clinical Trials, Fairfax
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 3, Charlottesville
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Blue Ridge Cancer Care - Blacksburg /ID# 281583, Blacksburg
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax
- Shenandoah Oncology /ID# 280699, Winchester
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NEXT Oncology Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Inova Schar Cancer Institute, Fairfax
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University Of Virginia Health System, Charlottesville
被験者募集中第2/3相
全年齢 · 全性別 · 2026/09/18更新 · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UVA Center for Psychiatric Clinical Research, Charlottesville
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- Bon Secours Westchester Emergency Center, Midlothian
- Bon Secours Saint Francis Medical Center, Midlothian
- 他3件
被験者募集中
18歳以上 · 全性別 · 2026/09/14更新 · NCT06756607A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
- NEXT Virginia ( Site 0054), Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/11更新 · NCT07247110A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- Virginia Commonwealth University ( Site 1008), Richmond
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06818643Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site number: 404, Fairfax
被験者募集中第1相
18歳以上 · 男性 · 2026/09/10更新 · NCT05997615A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- NEXT Oncology, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06440005Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Virginia Cancer Institute, Norfolk
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05386108A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Midlothian
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/09/08更新 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Virginia Health System, Charlottesville
- USO - Virginia Cancer Specialists, Fairfax
- VCU Health Adult Outpatient Pavillion, Richmond
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Prostate Active Surveillance Study
- Eastern Virginia Medical School, Norfolk
被験者募集中観察研究
21歳以上 · 男性 · 2026/09/02更新 · NCT00756665Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Hematology-Oncology Associates of Fredericksburg, Inc, Fredericksburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06072612A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- NEXT Virginia, Fairfax
被験者募集中第1相
18歳〜99歳 · 全性別 · 2026/09/01更新 · NCT06983743A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- NEXT Oncology, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07321106A Study of ARC-02 in B-cell NHL
- Massey Cancer Center, Richmond
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07691606Project: Every Child for Younger Patients With Cancer
- University of Virginia Cancer Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- 他3件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- University of Virginia Health System, Charlottesville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/19更新 · NCT04104776FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Virginia, Charlottesville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
- NEXT Oncology Virginia, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06759649Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Virginia Cancer Center, Charlottesville
- VCU Massey Comprehensive Cancer Center, Richmond
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314A Study of ASP1002 in Adults for Treatment of Solid Tumors
- NEXT Oncology Virginia, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT05719558Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 522, Fairfax
- 300, Norfolk
被験者募集中第2相
18歳以上 · 女性 · 2026/07/16更新 · NCT06906341A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Virginia Cancer Specialists, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05650632ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。